Analyst Ratings For NASDAQ:KMPH – KemPharm (NASDAQ:KMPH)
Today, Janney Montgomery Scott initiated coverage on NASDAQ:KMPH – KemPharm (NASDAQ:KMPH) with a Buy ➝ Buy with a price target of $17.00.
Some recent analyst ratings include
- 5/23/2018-Janney Montgomery Scott initiated coverage with a Buy ➝ Buy rating.
- 5/10/2018-Canaccord Genuity Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:KMPH – KemPharm (NASDAQ:KMPH)
NASDAQ:KMPH – KemPharm (NASDAQ:KMPH) has insider ownership of 25.90% and institutional ownership of 36.49%.
- On 5/15/2018 Daniel L Cohen, EVP, bought 7,900 with an average share price of $6.45 per share and the total transaction amounting to $50,955.00.
- On 11/27/2017 Daniel L Cohen, EVP, bought 7,500 with an average share price of $3.79 per share and the total transaction amounting to $28,425.00.
- On 9/25/2017 R. Laduane Clifton, CFO, bought 300 with an average share price of $3.78 per share and the total transaction amounting to $1,134.00.
- On 9/14/2017 Delaware Street Capital Master, Major Shareholder, bought 325,888 with an average share price of $3.27 per share and the total transaction amounting to $1,065,653.76.
- On 8/24/2017 Daniel L Cohen, EVP, bought 5,000 with an average share price of $2.58 per share and the total transaction amounting to $12,900.00.
- On 8/24/2017 Gordon K Johnson, Insider, bought 4,000 with an average share price of $2.60 per share and the total transaction amounting to $10,400.00.
- On 6/20/2017 Travis C Mickle, CEO, bought 8,000 with an average share price of $3.45 per share and the total transaction amounting to $27,600.00.
Recent Trading Activity for NASDAQ:KMPH – KemPharm (NASDAQ:KMPH)
Shares of NASDAQ:KMPH – KemPharm closed the previous trading session at 6.65 up +0.55 9.02% with 41533 shares trading hands.